Peter M. Lamb

Partner

シリコン・バレー, ポートランド

Peter Lamb, a partner working across our Bay Area and Pacific Northwest offices, is a member of the Corporate Group. Peter advises private equity sponsors, technology investors, and well established private and public technology and life sciences companies.

Peter advises private equity funds and their portfolio companies on M&A and minority and majority investments. He also advises a range of mid- to late-stage private technology companies, including Aptean, Duetto Research, ESS, ProCare, Qualifacts, Sagent Lending Solutions, Stripe, Trax Retail and Zimperium. Peter regularly works with Warburg Pincus on a wide range of technology, healthcare IT and life sciences platform investments and portfolio company transactions.

Peter has also advised on the IPOs and follow-ons of numerous companies, including Cortexyme, Twist Bioscience, Elevate Financial, AVG Technologies, Pandora Media, Chegg, Portola Pharmaceuticals and ZS Pharma. His experience includes a wide range of public and private company M&A, growth equity and public market financings for tech, life sciences and private equity clients, as well as numerous cross-border buy- and sell-side M&A representations, including the $1.3 billion sale of AVG Technologies to Avast Software, and a dozen roll-up acquisitions for TA Associates and Vista Equity-backed Aptean.

  • Select Growth Equity Representations

    • Warburg Pincus, Duetto, ESS, Mubadala, ProCare, Sagent Lending Solutions, Stripe, Trax Retail, Twist Bioscience, Zimperium.

    Select General Corporate Advisory Representations

    • Securities law compliance, corporate governance and reporting advice for companies such as AVG Technologies, Cortexyme, Stripe, Twist Bioscience and Zimperium.

    Select Mergers & Acquisitions

    • Warburg Pincus acquisition of Qualifacts Systems, Inc. from Great Hill Partners, LLC.

    • Aptean, a portfolio company of TA Associates and Vista Equity Partners, in a dozen add-on acquisitions.

    • Warburg Pincus portfolio companies in numerous add-on acquisitions.

    • Janrain in its sale to Akamai.

    • AVG in its $1.3 billion acquisition by Avast.

    • Ingram Micro in its $840 million acquisition of BrightPoint.

    • Micrel in its $840 million sale to Microchip.

    • Palm in its $1.2 billion sale to HP.

    • Planet Labs in its acquisition of Google’s Terra Bella satellite unit.

    • Routeware in its sale to Banneker Partners.

    • Shire in its asset sale of its Dermagraft business to Organogenesis.

    • Splunk in its acquisition of SignalSense.

    • Vector Capital in its acquisition of Symantec’s application management business.

    Select Pro Bono Representations

    • Numerous pro bono representations, including the National Center for Youth Law and Microcredit Enterprises, a non-profit microfinance organization, in the negotiation of its credit agreement with the Overseas Private Investment Corporation (OPIC). 

ニュースレター・著作

ニュース